Jeff Morris Jr. joins us to discuss how crypto can build products users love. Jeff is a venture capitalist and product genius who previously led Tinder's Revenue team as Tinder went from $20M to $1.2B in ARR and became the #1 grossing app in the App Store. In this conversation, we cover user acquisition and branding, the power of subscription business models, how to find crypto market fit, how to take advantage of platform shifts, learnings from NBA TopShot and more!
(01:08) Venture Narrative Whiplash
(08:20) Protocols as Open-Source Software
(11:41) The Power of Subscription Business Models
(15:24) Permissionless Plug
(22:32) Using Tokens to Incentivize Users
(23:32) Does Anything in Crypto Have Product Market Fit?
(28:36) How to Make Crypto More Accessible
(34:28) Decentralization vs User Experience
(42:31) What Verticals Are Underrated in Crypto?
(45:20) Learnings from NBA TopShot
(47:39) The Difficulty of Building Consumer Products
(52:49) A Founder’s "Earned Secret"
(58:11) Platform Shifts
(01:01:50) Launching on Multiple Chains & Distribution
(01:09:19) Writing Tips & Final Takeaways
Follow Jeff: https://twitter.com/jmj
Follow Mert: https://twitter.com/0xMert_
Follow Garrett: https://twitter.com/GarrettHarper_
Follow Lightspeed: https://twitter.com/Lightspeedpodhq
Subscribe on YouTube: https://bit.ly/43o3Syk
Subscribe on Apple: https://apple.co/3OhiXgV
Subscribe on Spotify: https://spoti.fi/3OkF7PD
Get top market insights and the latest in crypto news. Subscribe to Blockworks Daily Newsletter: https://blockworks.co/newsletter/
Use code LIGHTSPEED30 to get 30% off Permissionless 2023 in Austin: https://blockworks.co/event/permissionless-2023
Lightspeed was kickstarted by a grant from the Solana Foundation.
Nothing said on Lightspeed is a recommendation to buy or sell securities or tokens. This podcast is for informational purposes only, and any views expressed by anyone on the show are solely our opinions, not financial advice. Mert, Garrett and our guests may hold positions in the companies, funds, or projects discussed.